Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Estrogen requirements in girls with Turner syndrome; how low is enough for initiating puberty and uterine development?

Kim NY, Lee DY, Kim MJ, Yoon BK, Choi D.

Gynecol Endocrinol. 2012 Feb;28(2):130-3. doi: 10.3109/09513590.2011.588752. Epub 2011 Jul 27.

PMID:
21793702
2.

Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.

Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM.

Clin Endocrinol (Oxf). 2009 Feb;70(2):265-73. doi: 10.1111/j.1365-2265.2008.03446.x.

PMID:
19200215
3.

The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose.

Snajderova M, Mardesic T, Lebl J, Gerzova H, Teslik L, Zapletalova J; Czech National Study Group for HRT Optimization in Paediatric and Adolescent Endocrinology and Gynaecology.

Horm Res. 2003;60(4):198-204.

PMID:
14530609
4.

Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome.

Nakamura T, Tsuburai T, Tokinaga A, Nakajima I, Kitayama R, Imai Y, Nagata T, Yoshida H, Hirahara F, Sakakibara H.

Endocr J. 2015;62(11):965-70. doi: 10.1507/endocrj.EJ15-0172. Epub 2015 Aug 18.

5.

Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.

Nabhan ZM, Dimeglio LA, Qi R, Perkins SM, Eugster EA.

J Clin Endocrinol Metab. 2009 Jun;94(6):2009-14. doi: 10.1210/jc.2008-2123. Epub 2009 Mar 24.

PMID:
19318455
6.
7.

Uterine development in patients with Turner syndrome: relation to hormone replacement therapy and karyotype.

Elsedfy HH, Hamza RT, Farghaly MH, Ghazy MS.

J Pediatr Endocrinol Metab. 2012;25(5-6):441-5.

PMID:
22876536
8.

Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001.

Doerr HG, Bettendorf M, Hauffa BP, Mehls O, Partsch CJ, Said E, Sander S, Schwarz HP, Stahnke N, Steinkamp H, Ranke MB.

Hum Reprod. 2005 May;20(5):1418-21. Epub 2005 Feb 3.

PMID:
15695313
9.

Retrospective evaluation of pubertal development and linear growth of girls with Turner Syndrome treated with oral and transdermal estrogen.

Çakır ED, Sağlam H, Eren E, Özgür T, Tarım ÖF.

J Pediatr Endocrinol Metab. 2015 Nov 1;28(11-12):1219-26. doi: 10.1515/jpem-2014-0007.

PMID:
25968434
10.

Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome.

Piippo S, Lenko H, Kainulainen P, Sipilä I.

J Clin Endocrinol Metab. 2004 Jul;89(7):3241-7.

PMID:
15240598
11.

Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients.

Kodama M, Komura H, Kodama T, Nishio Y, Kimura T.

Endocr J. 2012;59(2):153-9. Epub 2011 Dec 3.

12.

Physiological estrogen replacement therapy for puberty induction in girls: a clinical observational study.

Ankarberg-Lindgren C, Kriström B, Norjavaara E.

Horm Res Paediatr. 2014;81(4):239-44. doi: 10.1159/000356922. Epub 2014 Feb 4.

13.

Poor uterine development in Turner syndrome with oral oestrogen therapy.

Paterson WF, Hollman AS, Donaldson MD.

Clin Endocrinol (Oxf). 2002 Mar;56(3):359-65.

PMID:
11940048
14.

CHARACTERIZATION OF SPONTANEOUS AND INDUCED PUBERTY IN GIRLS WITH TURNER SYNDROME.

Folsom LJ, Slaven JE, Nabhan ZM, Eugster EA.

Endocr Pract. 2017 Jul;23(7):768-774. doi: 10.4158/EP161738.OR. Epub 2017 Mar 23.

PMID:
28332872
15.

The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.

Aycan Z, Cetinkaya E, Darendeliler F, Vidinlisan S, Bas F, Bideci A, Demirel F, Darcan S, Buyukgebiz A, Yildiz M, Berberoglu M, Bundak R.

Clin Endocrinol (Oxf). 2008 May;68(5):769-72. Epub 2007 Nov 2.

PMID:
17980015
16.

Uterine development in Turner syndrome.

Bakalov VK, Shawker T, Ceniceros I, Bondy CA.

J Pediatr. 2007 Nov;151(5):528-31, 531.e1. Epub 2007 Sep 17.

17.

The importance of estrogen replacement in young women with Turner syndrome.

Hanton L, Axelrod L, Bakalov V, Bondy CA.

J Womens Health (Larchmt). 2003 Dec;12(10):971-7.

PMID:
14709185
18.

A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound.

McDonnell CM, Coleman L, Zacharin MR.

Clin Endocrinol (Oxf). 2003 Apr;58(4):446-50.

PMID:
12641627
19.

[The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].

Sowińska-Przepiera E, Andrysiak-Mamos E, Friebe Z, Kapczuk K, Pilarska K.

Endokrynol Pol. 2005 Mar-Apr;56(2):145-53. Polish.

PMID:
16335682
20.

Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.

Perry RJ, Gault EJ, Paterson WF, Dunger DB, Donaldson MD.

Horm Res Paediatr. 2014;81(5):298-308. doi: 10.1159/000356924. Epub 2014 Apr 15.

PMID:
24751470

Supplemental Content

Support Center